Technology News and Research

RSS

Untreated gum disease has potentially dangerous implications

The American Academy of Periodontology (AAP) estimates that approximately three out of four Americans suffer from some form of gum disease -- from mild cases of gingivitis, to the more severe form known as periodontitis. However, despite this prevalence, approximately only three percent seek treatment for their gum disease. With increasingly more research indicating that gum disease may be linked to several other diseases, including diabetes, heart disease and certain forms of cancer, maintaining healthy teeth and gums has become more important that ever.

19 Feb 2010

Researchers develop technology to preserve vaccines in tropical temperatures

A team of British researchers have developed a simple, low-cost method to preserve vaccines in tropical climates, which they say could help to revolutionalize vaccination campaigns in developing countries, Reuters reports.

19 Feb 2010

Efficient healthcare system in sub-Saharan Africa can reduce maternal deaths

More than 500,000 women die each year worldwide due to complications arising from pregnancy and childbirth. Half of these women live in sub-Saharan Africa. A research team from the King Juan Carlos University (URJC) in Madrid says these women are not dying as a result of any illness, but rather from a lack of basic healthcare measures.

19 Feb 2010

Kaiser Permanente honored as the fifth Most Innovative Health Care Company for pioneering EHR

Kaiser Permanente has been honored in Fast Company's annual Most Innovative Companies issue as the fifth Most Innovative Health Care Company in the World for its pioneering electronic health record that is the world's largest civilian electronic health record, and for its health care innovation center that develops the future of health care.

19 Feb 2010

Echo Therapeutics makes significant advance in designing Symphony tCGM device

Echo Therapeutics, Inc., a company developing the needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, announced today that the Company has made a significant advance in the product design of its Symphony tCGM device and that it has developed its next generation electronic component package.

19 Feb 2010

Secretary of Veterans Affairs launches HIT initiative to improve healthcare delivery

Secretary of Veterans Affairs Eric K. Shinseki launched the "Veterans Health IT Innovation Initiative," an employee-based Health Information Technology (HIT) competition to spur VA's transformation into a 21st Century organization that is Veteran-centric, results-oriented, and forward-looking.

19 Feb 2010

New report shows dramatic rise in medical technology, pharmaceuticals and healthcare costs

Management of Emerging Healthcare Solutions, Inc. (Pinksheets: EHSI) stated that they were encouraged by a new report that parallels the company’s conclusions about the new potential for business in the current healthcare marketplace.

19 Feb 2010

Blood transfusions based on single low hematocrit measurement questioned

A comparison study of nearly 1,900 patients published in Perfusion, a peer-reviewed academic journal, questions the long-standing practice of basing blood transfusion decisions on a single low hematocrit measurement result. In the study, titled Is it the Patient or the Physician who Cannot Tolerate Anemia?, researchers showed that a single measure of hematocrit is not a reliable indicator of transfusion need and that lower-than-normal hemoglobin levels have no adverse impact on patients.

19 Feb 2010

UCSF, Genentech partner to discover and develop drug candidates for neurodegenerative diseases

The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug candidates for neurodegenerative diseases.

19 Feb 2010

Johns Hopkins Kimmel Cancer Center scientists develop genome-based blood tests for cancer

Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.

19 Feb 2010

Cellular metabolism plays a key role in cancer development

It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy -- can have much more sinister effects than making it hard to fit into your favorite jeans.

19 Feb 2010

The Hamner Institutes signs formal Memorandum of Understanding with Oslo Cancer Cluster

The Hamner Institutes at Research Triangle Park has signed a formal Memorandum of Understanding with the Oslo Cancer Cluster in Oslo, Norway, one of the leading cancer clusters in Europe. The goal of the collaboration is to strengthen The Hamner's Global BioScience Gateway for Translational Research and Business Development, which began with partnerships in China.

19 Feb 2010

Neuralstem raises $5.25M, also receives NYSE Amex compliance notice

Neuralstem, Inc. announced today that it has raised a total of $5,228,000 since the beginning of the year, comprised of a previously disclosed $1.5 million private placement of 646,551 common shares at $2.32, priced at a 30 percent premium over the market on the closing, and approximately $3.7 million from warrant exercises.

19 Feb 2010

Report examines how medical technology changes state of health care

Federal researchers Wednesday released a report that examines how medical technology is changing the state of health care.

19 Feb 2010

RainDance Technologies enters into strategic agreement with Applied Biosystems

RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.

19 Feb 2010

Walker's book focuses on deaths, genetic deformities and other health issues resulting from environmental pollution

Since the brain-injuring virus needs mosquitoes and pigs to spread, government officials should ban standing water in cemetery cisterns and urban drainage ditches. They should keep industrial "piggeries" away from cities and their populations.

19 Feb 2010

Beacon Partners continues to grow to meet the needs of healthcare industry

As the healthcare community continues to ready itself to make the most of the stimulus funds in accordance with the ARRA, healthcare management consulting firm Beacon Partners’ growth pattern continues with an aggressive hiring pattern to meet the needs of the healthcare industry.

19 Feb 2010

The Methodist Hospital Research Institute awarded $11.5M NIH grant for research into methods of targeting cancer stem cells

The Methodist Hospital Research Institute was awarded an $11.5 million Center Grant by the National Institutes for Health (NIH) today to study the best way to attack deadly cancer stem cells to enhance treatments for breast cancer. Other members of the team include Baylor College of Medicine and the University of Texas Health Science Center at Houston.

19 Feb 2010

IMS Health launches IMS Aggregate Spend Compliance Services

IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS Aggregate Spend Compliance Services, a comprehensive set of solutions to help pharmaceutical and medical device companies comply with the growing number of federal and state transparency and marketing disclosure laws in the U.S., known as “aggregate spend” reporting regulations.

18 Feb 2010

Anulex Technologies announces the commercial availability of Xclose Plus Tissue Repair System

Anulex Technologies, Inc., a privately held medical device manufacturer focusing on spinal disc Preservation & Anular Repair™ products, announced the commercial availability of the Xclose™ Plus Tissue Repair System at the AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves meeting in Orlando, Florida.

18 Feb 2010

Technology News and Research

Untreated gum disease has potentially dangerous implications

Researchers develop technology to preserve vaccines in tropical temperatures

Efficient healthcare system in sub-Saharan Africa can reduce maternal deaths

Kaiser Permanente honored as the fifth Most Innovative Health Care Company for pioneering EHR

Echo Therapeutics makes significant advance in designing Symphony tCGM device

Secretary of Veterans Affairs launches HIT initiative to improve healthcare delivery

New report shows dramatic rise in medical technology, pharmaceuticals and healthcare costs

Blood transfusions based on single low hematocrit measurement questioned

UCSF, Genentech partner to discover and develop drug candidates for neurodegenerative diseases

Johns Hopkins Kimmel Cancer Center scientists develop genome-based blood tests for cancer

Cellular metabolism plays a key role in cancer development

The Hamner Institutes signs formal Memorandum of Understanding with Oslo Cancer Cluster

Neuralstem raises $5.25M, also receives NYSE Amex compliance notice

Report examines how medical technology changes state of health care

RainDance Technologies enters into strategic agreement with Applied Biosystems

Walker's book focuses on deaths, genetic deformities and other health issues resulting from environmental pollution

Beacon Partners continues to grow to meet the needs of healthcare industry

The Methodist Hospital Research Institute awarded $11.5M NIH grant for research into methods of targeting cancer stem cells

IMS Health launches IMS Aggregate Spend Compliance Services

Anulex Technologies announces the commercial availability of Xclose Plus Tissue Repair System

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News